CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice Management

 

Communicating Risks of Contrast Agents to Patients

By Whitney L.J. Howell | January 29, 2013

One of the most commonly used imaging tools in a radiologist’s arsenal is the contrast agent. It enhances the appearance of structures and fluids, but it isn’t without risks and challenges. And, it’s up to radiologists, industry experts say, to make sure your patients and staff understand how to use it and why.

While less than 1 percent of patients experience a negative response to a contrast agent, according to a Mayo Clinic study, everyone involved with a scan using contrast should be aware of all possible outcomes and know how to handle them. The American College of Radiology offers guidance in how to best administer these agents, but creating the optimal experience for the patient involves more than selecting the right agent and using the correct measurement.

(MORE: A Push for LEU Isotopes: What it Means for Imaging)

“You’re giving someone a drug, and there’s a risk to that. Patients have to understand that risk,” said Lawrence Marks, MD, chair of radiation oncology at the University of North Carolina at Chapel Hill School of Medicine. “They have to understand the value of the test, but like everything else in medicine, your actions should be based on a discussion with the patient before you do it.”

Educating the Patient

Although the risks can be minor, you should always consider if using contrast is even necessary, said Jeffrey Kanne, MD, associate professor of thoracic imaging and quality and safety vice chair at the University of Wisconsin School of Medicine and Public Health. If you can obtain the same information with the same level of specificity without using an agent, then do so, he said. That is always the safest option.

However, if contrast media is necessary, make it as easy to understand as possible. Like many procedures in radiology, the use of contrast media includes complex terminology that is potentially unfamiliar to patients. Always explain what the contrast media is and what it does in basic terminology — then, employ the teach-back method.

“Make sure you have patients explain back to you what you said. It’s a very valid way of ensuring patients truly understand,” Kanne said. “If they can recount back, you know they understand. If not, it’s clear you haven’t communicated effectively, and you need to try a different approach.”

One such strategy is a patient education website that addresses the risks associated with contrast media and tells patients what information you will need to ensure not only their safety, but also the best imaging results. For example, the University of Washington Medical Center maintains a patient education page that answers questions about need and risk in easy-to-understand language.

In addition, be willing to sit with patients and give them the opportunity to voice their questions and concerns. The most common worry patients have, Kanne said, is the misconception that contrast agents are radioactive. Others — many of whom experienced previous-generation contrast agents — fear the procedure will be painful and cause a burning sensation.

Training Your Staff

To ensure your providers and technologists have a full understanding of contrast media and the associated challenges, consider partnering with a pharmacy either within your facility or nearby. According to the American Society of Health-System Pharmacists (ASHP), working more closely with the individuals who prepare the contrast media could help you better educate your colleagues.

For instance, said Niesha Griffith, MS, RPh, the pharmacy and infusion services director at Ohio State University Medical Center, change these terms you use to describe contrast media.

“Our biggest challenge was in changing the culture,” Griffith said during a previous ASHP clinical meeting presentation. “We encouraged the radiologists and the technologists to refer to the contrast agents as medications, and not just within the department, but also when talking to patients. Accomplishing that required a lot of education and reinforcement.”

One of the most effective education and safety tools Ohio implemented, she said, was pocket cards for technologists. A pocket card exists for each contrast agent, and it includes all the generic and brand names of medications that interact negatively with the agent. This strategy enables technologists to double-check the procedure one last time and contact the radiologist if there are any red flags.

It’s also imperative that any technologist in your practice or department who is charged with administering contrast agents has received the proper training, Kanne said. Each type of scan should have an individual protocol, developed by a radiologist and the medical physicist team, that specifies which contrast, the dosage, and the route given, all adjusted for weight and size. Have a standard for IV placement, and keep this information where technologists can readily access it.

Ultimately, Kanne said, it’s your responsibility to ensure an imaging study using contrast goes as smoothly as possible for the patient.

“You should make the patient feel that when they come in for a test, you’re available to talk with them,” he said. “We don’t have a lot of patient contact as radiologists, but if patients understand that a physician trained in medical imaging is immediately available to speak with them, it can have a very beneficial impact on their experience.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Irene Campbell-Taylor | February 01, 2013 11:36 AM EST

Barium is equally a drug but I have found that, especially with swallowing videofluoroscopy, no-one takes the time to explain to the patient the relative safety of barium if aspirated. Unfortunately there is a common practice of mixing food with barium - a practice of no value whatsoever- but one that causes hazard if aspiration of food plus barium occurs.
Irene Campbell-Taylor MB ChB,, PhD.
Clinical Neuroscientist
Drirenect@aol.com

Related Articles

Low-Osmolar Contrast Agents: Why Their Rise Is Important

Major European congress focuses on contrast agents

MRI Contrast Agent Prototype Targets Cancers

A Push for LEU Isotopes: What it Means for Imaging

Communicating Risks of Contrast Agents to Patients






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Practice Management
Evidence on Practice Management
Guidelines on Practice Management
Patient Education on Practice Management
Clinical Trials on Practice Management
Practical Articles on Practice Management
Research and Reviews on Practice Management
All "Practice Management" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy